For adults with mild cognitive impairment (MCI) or mild dementia due to Alzheimer disease, amyloid-beta-targeted monoclonal antibodies have negligible or little effect, according to a study published ...

Recognizing the signs of mild cognitive impairment meant Di could start treatment earlier to help slow her Alzheimer's ...